Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 12 months, Helvetia Baloise Holding AG's average EBITDA Per Share Growth Rate was 6.80% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 11.50% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 7.20% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 4.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Helvetia Baloise Holding AG was 15.30% per year. The lowest was -10.70% per year. And the median was 1.10% per year.
Helvetia Baloise Holding AG (XSWX:HBAN) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Helvetia Baloise Holding AG 5-Year EBITDA Growth Rate Related Terms
XSWX:HBAN vs BRK.A, AIG, HIG: 5-Year EBITDA Growth Rate Comparison
For the Insurance - Diversified subindustry, Helvetia Baloise Holding AG's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Helvetia Baloise Holding AG 5-Year EBITDA Growth Rate vs Insurance Industry
For the Insurance industry and Financial Services sector, Helvetia Baloise Holding AG's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Helvetia Baloise Holding AG's 5-Year EBITDA Growth Rate falls into.
Helvetia Baloise Holding AG 5-Year EBITDA Growth Rate Calculation
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 5-Year EBITDA Growth Rate of 7.20% mean?
Helvetia Baloise Holding AG (XSWX:HBAN) has a 5-Year EBITDA Growth Rate of 7.20% as of Dec. 2025. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Helvetia Baloise Holding AG and its competitors.
Is Helvetia Baloise Holding AG's 5-Year EBITDA Growth Rate too high?
Helvetia Baloise Holding AG's current 5-Year EBITDA Growth Rate is 7.20%. Overall, Helvetia Baloise Holding AG has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Helvetia Baloise Holding AG's 5-Year EBITDA Growth Rate compare to BRK.A and AIG?
Helvetia Baloise Holding AG's 5-Year EBITDA Growth Rate of 7.20% can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year EBITDA Growth Rate for an Insurance company?
A good 5-Year EBITDA Growth Rate depends on the Insurance industry context. However, 5-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year EBITDA Growth Rate mean?
A high 5-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 5-Year EBITDA Growth Rate is the 5-year average growth rate of EBITDA per share. View historical data for Helvetia Baloise Holding AG and its competitors. Helvetia Baloise Holding AG's current 5-Year EBITDA Growth Rate is 7.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Helvetia Baloise Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Helvetia Baloise Holding AG (XSWX:HBAN) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF192.51, compared to a current price of CHF215.20 — trading 11.8% above its estimated fair value. The current 5-Year EBITDA Growth Rate is 7.20%. Helvetia Baloise Holding AG's overall GF Score™ is 82/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year EBITDA Growth Rate calculated?
5-Year EBITDA Growth Rate is calculated from a company's financial statements. For Helvetia Baloise Holding AG (XSWX:HBAN), the current 5-Year EBITDA Growth Rate is 7.20% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Helvetia Baloise Holding AG (XSWX:HBAN) Overvalued in 2026?
Based on GuruFocus' analysis, Helvetia Baloise Holding AG stock appears to be overvalued.
The current stock price of CHF215.20 is trading 11.8% above its estimated GF Value™ of CHF192.51.
GuruFocus considers Helvetia Baloise Holding AG to be Modestly Overvalued.
Key valuation signals for XSWX:HBAN:
5-Year EBITDA Growth Rate: 7.20%
GF Value™: CHF192.51 vs. price of CHF215.20 (11.8% above fair value)
No single metric tells the full story. See the XSWX:HBAN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Helvetia Baloise Holding AG is a multi-line insurance company. The company provides pension, specialty insurance and reinsurance services, and other financial solutions. The company represents it's seven reportable segments namely Switzerland, Spain, Germany, Belgium, Luxembourg, Italian and Austrian Markets, Specialty Markets, and Corporate and other. Company generates majority revenue from Switzerland business segment.
82GF Score
Get the complete analysis for XSWX:HBAN
5-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:HBAN has been successfully added to your 
